100+ total transactions representing $2B+ in aggregate value — 10 tracked below spanning 2013–2025 · 5 industries
Fairness opinion provided to SPAC board for de-SPAC transaction with Huajin.
Equity financing advisory for NASDAQ-listed biotechnology company.
Advisory services on $125M real estate investment fund syndication.
Syndicate member on $100M+ EB-5 investment fund for job-creating real estate project.
M&A advisory for NASDAQ-listed VR/AR company (NASDAQ: VRAR).